FilingSEC EDGAR8-K
Vistagen Therapeutics Announces Results of 2026 Annual Meeting
· SEC accepted
StageAnnual meeting completed
Filing content
Vistagen Therapeutics held its 2026 Annual Meeting, where stockholders elected directors, approved executive compensation, and ratified the appointment of independent auditors.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…